Hepatotsyytit

Hepatotsyytit is a viral infection primarily affecting the liver, caused by the hepatitis C virus (HCV). It is a significant global health concern, with an estimated 71 million people infected worldwide as of 2015. The virus is transmitted through blood-to-blood contact, most commonly through sharing needles among intravenous drug users, but it can also be transmitted through blood transfusions, organ transplants, and from mother to child during childbirth.

Hepatitis C is a chronic infection, meaning it can persist in the body for years without causing symptoms. However, it can lead to serious liver damage, including cirrhosis and liver cancer. The disease is more prevalent in certain populations, such as men who have sex with men, people who inject drugs, and individuals from countries with high rates of HCV transmission.

Diagnosis of hepatitis C typically involves blood tests that detect the presence of the virus. Treatment options have significantly improved in recent years, with the introduction of direct-acting antiviral drugs that can cure the infection in most cases. Early diagnosis and treatment are crucial for preventing the progression of liver damage and reducing the risk of complications.

Prevention strategies focus on reducing the risk of blood-to-blood contact, including safe injection practices, the use of sterile needles and syringes, and screening blood donations for HCV. Vaccines are not available for hepatitis C, making prevention efforts reliant on public health measures and education.